Quantitative Phosphoproteomic Analysis Identifies the Potential Therapeutic Target EphA2 for Overcoming Sorafenib Resistance in Hepatocellular Carcinoma Cells
Experimental and Molecular Medicine - United States
doi 10.1038/s12276-020-0404-2
Full Text
Open PDFAbstract
Available in full text
Date
March 19, 2020
Authors
Publisher
Springer Science and Business Media LLC